ALPHA-IONENE
General Information
Mainterm | ALPHA-IONENE |
Doc Type | EAF |
CAS Reg.No.(or other ID) | 475-03-6 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 68057 |
IUPAC Name | 4,4,7-trimethyl-2,3-dihydro-1H-naphthalene |
InChI | InChI=1S/C13H18/c1-10-6-7-12-11(9-10)5-4-8-13(12,2)3/h6-7,9H,4-5,8H2,1-3H3 |
InChI Key | LTMQZVLXCLQPCT-UHFFFAOYSA-N |
Canonical SMILES | CC1=CC2=C(C=C1)C(CCC2)(C)C |
Molecular Formula | C13H18 |
Wikipedia | α-ionene |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 174.287 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 0 |
Complexity | 181.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w A A A A A A A A A A A A A A A A A A A A A A A A A A A w Y A A A A A A A A A D B A A A A G A A A A A A A D g C A G A A y A I A A A A C A A i B C A A A C A A A g A A A I i A A A A I g I I C K A E R C A I A A g g A A I i A c A g M A P w A A C A A A Q A A C A A A Q A A C A A A A A A A A A A A A = = |
Topological Polar Surface Area | 0.0 |
Monoisotopic Mass | 174.141 |
Exact Mass | 174.141 |
XLogP3 | None |
XLogP3-AA | 4.5 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 13 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9891 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.7588 |
P-glycoprotein Substrate | Substrate | 0.5329 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6140 |
Inhibitor | 0.6357 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.7624 |
Distribution | ||
Subcellular localization | Lysosome | 0.6905 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7649 |
CYP450 2D6 Substrate | Non-substrate | 0.7458 |
CYP450 3A4 Substrate | Substrate | 0.5967 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8393 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8906 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8897 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7699 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9248 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7666 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9659 |
Non-inhibitor | 0.5310 | |
AMES Toxicity | Non AMES toxic | 0.6013 |
Carcinogens | Non-carcinogens | 0.7809 |
Fish Toxicity | High FHMT | 0.9882 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9965 |
Honey Bee Toxicity | High HBT | 0.6897 |
Biodegradation | Not ready biodegradable | 0.9364 |
Acute Oral Toxicity | IV | 0.6546 |
Carcinogenicity (Three-class) | Non-required | 0.4804 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -6.3774 | LogS |
Caco-2 Permeability | 1.8223 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.3557 | LD50, mol/kg |
Fish Toxicity | -0.5698 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.9992 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Benzenoids |
Class | Tetralins |
Subclass | Not available |
Intermediate Tree Nodes | Not available |
Direct Parent | Tetralins |
Alternative Parents | |
Molecular Framework | Aromatic homopolycyclic compounds |
Substituents | Tetralin - Aromatic hydrocarbon - Polycyclic hydrocarbon - Unsaturated hydrocarbon - Hydrocarbon - Aromatic homopolycyclic compound |
Description | This compound belongs to the class of organic compounds known as tetralins. These are polycyclic aromatic compounds containing a tetralin moiety, which consists of a benzene fused to a cyclohexane. |
From ClassyFire